Rafael Holdings

0 followers

‌

Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.

Industries

Headquarters

Stage

Employees

Links

Org chart

William Conkling

CEO

William Conkling

Collapse

David Polinsky

Chief Financial Officer

Ari Landon

Director Of Innovation

Teams

Board of Directors

8 members

CEO and Executive Team

1 members

Leadership Team

1 members

Similar companies

Dyno Therapeutics

4 followers

BioMarin Pharmaceutical

20 followers

Adaptive Biotechnologies

11 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Discover companies